<clinical_study rank="129070">
  
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 05, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01079299</url>
  </required_header>
  <id_info>
    <org_study_id>CL-VU-0308</org_study_id>
    <nct_id>NCT01079299</nct_id>
  </id_info>
  <brief_title>Effect of Intermittent Pneumatic Compression on Ulcer Healing in Subjects With Secondary Lymphedema</brief_title>
  <official_title>Intermittent, Gradient, Pneumatic Compression Plus Standard Compression for Hard-To-Heal Venous Ulcers in Subjects With Secondary Lymphedema and Chronic Venous Insufficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Calvary Hospital, Bronx, NY</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>RTS Family Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>New York State Department of Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Calvary Hospital, Bronx, NY</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, controlled, parallel group, open label, clinical trial to evaluate the
      effectiveness of intermittent, gradient, pneumatic compression (IPC)on the healing of venous
      ulcers in subjects diagnosed with chronic secondary lymphedema. Time to complete healing,
      healing rates, edema, wound pain, granulation tissue, and wound exudate (type and amount)
      will be compared between the IPC-treated group (IPC plus standard compression)and control
      (standard compression alone).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2007</start_date>
  <completion_date type="Actual">May 2010</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Median Time to Wound Closure at 9 Months</measure>
    <time_frame>9 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Median number of days for complete healing in each treatment group</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Lymphedema</condition>
  <arm_group>
    <arm_group_label>IPC plus standard compression</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard compression alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intermittent, gradient, pneumatic compression device</intervention_name>
    <description>lymphedema pump provides external compression in a segmental,gradient fashion</description>
    <arm_group_label>IPC plus standard compression</arm_group_label>
    <arm_group_label>Standard compression alone</arm_group_label>
    <other_name>Bio 4000 (Bio Compression Inc, Moonachie,NJ)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with secondary lymphedema

          -  Presence of a venous ulcer that has not healed in more than 6 months

          -  Localized wound pain greater than 3 with VAS

          -  Ulcer must be on lower leg (below knee)

          -  Ulcer must be of venous etiology

          -  CVI proven by duplex studies

          -  Subject must have adequate arterial blood flow (ABI &gt; 0.70)

          -  Subject must be able to tolerate compression bandages

          -  Subject must be ambulatory

          -  Capable of understanding consent process

        Exclusion Criteria:

          -  Wound infection

          -  Ulcer of non-venous etiology

          -  Ulcer on toes or plantar surface of the foot

          -  Subject taking any medication that in the opinion of the investigator affects wound
             healing

          -  Alcohol or drug abuse

          -  Active deep venous thrombosis (DVT)

          -  Subject has a cancer diagnosis

          -  Diabetic with hemoglobin A1C&gt;12

          -  Arterial insufficiency ABI&lt;0.70

          -  Subject is not capable of walking (wheelchair-bound or bed-bound)

          -  Subject currently enrolled in another clinical trial

          -  Moderate to severe congestive heart failure
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Calvary Hospital, Center for Curative and Palliative Wound Care</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2010</verification_date>
  <lastchanged_date>January 9, 2012</lastchanged_date>
  <firstreceived_date>March 2, 2010</firstreceived_date>
  <firstreceived_results_date>August 18, 2011</firstreceived_results_date>
  <responsible_party>
    <name_title>Oscar M. Alvarez, PhD / Principal Investigator</name_title>
    <organization>Center for curative and Palliative Wound Care, Calvary Hospital</organization>
  </responsible_party>
  <keyword>venous ulcer</keyword>
  <keyword>secondary lymphedema</keyword>
  <keyword>chronic lower leg ulceration</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    
    <mesh_term>Lymphedema</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>52 subjects were treated, IPC n=27, Control n=25</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>IPC Plus Standard Compression</title>
        </group>
        <group group_id="P2">
          <title>Standard Compression Alone</title>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants count="27" group_id="P1" />
                <participants count="25" group_id="P2" />
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants count="27" group_id="P1" />
                <participants count="25" group_id="P2" />
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants count="0" group_id="P1" />
                <participants count="0" group_id="P2" />
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>IPC Plus Standard Compression</title>
        </group>
        <group group_id="B2">
          <title>Standard Compression Alone</title>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="27" />
                <measurement group_id="B2" value="25" />
                <measurement group_id="B3" value="52" />
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0" />
                <measurement group_id="B2" value="0" />
                <measurement group_id="B3" value="0" />
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="11" />
                <measurement group_id="B2" value="13" />
                <measurement group_id="B3" value="24" />
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="16" />
                <measurement group_id="B2" value="12" />
                <measurement group_id="B3" value="28" />
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" spread="5.6" value="66" />
                <measurement group_id="B2" spread="4.9" value="59" />
                <measurement group_id="B3" spread="5" value="62" />
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="10" />
                <measurement group_id="B2" value="9" />
                <measurement group_id="B3" value="19" />
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="17" />
                <measurement group_id="B2" value="16" />
                <measurement group_id="B3" value="33" />
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United States</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="27" />
                <measurement group_id="B2" value="25" />
                <measurement group_id="B3" value="52" />
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Median Time to Wound Closure at 9 Months</title>
        <description>Median number of days for complete healing in each treatment group</description>
        <time_frame>9 months</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>IPC Plus Standard Compression</title>
          </group>
          <group group_id="O2">
            <title>Standard Compression Alone</title>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="27" />
                  <measurement group_id="O2" value="25" />
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Median Time to Wound Closure at 9 Months</title>
            <description>Median number of days for complete healing in each treatment group</description>
            <units>median number of days for complete heali</units>
            <param>Median</param>
            <dispersion>Standard Error</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" spread="24" value="141" />
                  <measurement group_id="O2" spread="29" value="211" />
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>IPC Plus Standard Compression</title>
        </group>
        <group group_id="E2">
          <title>Standard Compression Alone</title>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27" />
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25" />
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27" />
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25" />
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Oscar M. Alvarez / Principal Investigator</name_or_title>
      <organization>Center for Curative and Palliative Wound Care Calvary Hospital</organization>
      <phone>718-518-2577</phone>
      <email>oalvarez@calvaryhospital.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>